Currently, particular attention is paid to public health related to the field of γ-ray dosimetry, which is becoming increasingly important in medical diagnostic processes. Incorporating sensitive dyes as radiation dose sensors in different material hosts has shown promising radiation dosimetry application routes. In this perspective, the current study proposes a new fluorescent dye based on boron difluoride complex, the pyridomethene-BF2 named 2-(1-(difluoroboraneyl)-1,2-dihydroquinolin-2-yl)-2-(1-methylquinoxalin-2-ylidene) acetonitrile (DBDMA) as an indicator for low γ-ray doses. The different optical and quantum chemical parameters and the spectral behavior of the selected fluorescent dye were first studied. Then, PVP/DBDMA electrospun nanofibers and PVA/DBDMA thin films were prepared. The different UV-vis spectrophotometric and fluorescence studies revealed a clear change after exposure to different γ-ray doses. Thermogravimetric analysis exhibited excellent thermal stability of the prepared nanocomposite films, showing altered thermal behavior after γ-ray treatment. Furthermore, the SEM evaluation displayed a significant modification in the surface morphology of the two designed nanomaterials with increased radiation dose intensity. These novel forms of dosimeter designed in nanoscale composites could therefore constitute a promising and efficient alternative for rapid and accurate detection of low doses of γ-rays in various medical applications.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520551 | PMC |
http://dx.doi.org/10.1021/acsomega.2c03174 | DOI Listing |
Infect Dis (Lond)
January 2025
Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, Athens, GA, USA.
Background: Whether a detected virus or bacteria is a pathogen that may require treatment, or is merely a commensal 'passenger', remains confusing for many infections. This confusion is likely to increase with the wider use of multi-pathogen PCR.
Objectives: To propose a new statistical procedure to analyse and present data from case-control studies clarifying the probability of causality.
Cardiovasc Toxicol
January 2025
Department of Morphological Sciences, State University of Maringa, Maringa, Parana, Brazil.
5-Fluorouracil (5-FU) is a chemotherapeutic that is used to treat solid tumors. However, 5-FU is associated with several side effects, including cardiotoxicity. Considering the importance of the intrinsic cardiac nervous system (ICNS) for the heart and that little is known about effects of 5-FU on this nervous system plexus, the purpose of the present study was to evaluate effects 5-FU at a low dose on the ICNS and oxidative and inflammatory effects in the heart in Wistar rats.
View Article and Find Full Text PDFPediatr Surg Int
January 2025
Division of Pediatric Surgery, Department of Surgery, University of Florida College of Medicine, PO Box 100119, Gainesville, FL, 32610-0119, USA.
Purpose: Initial recommendations for ECMO had relative contraindications for low birth weight (BW) or low gestational age (GA) babies. However, more recent literature has demonstrated improved and acceptable outcomes of ECMO in smaller neonates. The purpose of this study was to understand both utilization and survival in patients with lower GA and BW.
View Article and Find Full Text PDFEJNMMI Phys
January 2025
Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Solna, Sweden.
Background: System calibration is essential for accurate SPECT/CT dosimetry. However, count losses due to dead time and pulse pileup may cause calibration errors, in particular for I, where high count rates may be encountered. Calibration at low count rates should also be avoided to minimise detrimental effects from e.
View Article and Find Full Text PDFInt J Radiat Oncol Biol Phys
January 2025
Providence Swedish Cancer Institute, Seattle, Washington.
Purpose: Standard therapy for breast cancer after breast-conserving surgery is radiation therapy (RT) plus hormone therapy (HT). For patients with a low-risk of recurrence, there is an interest in deescalating therapy.
Methods And Materials: A retrospective study was carried out for patients treated at the Swedish Cancer Institute from 2000 to 2015, aged 70 years or older, with pT1N0 or pT1NX estrogen receptor-positive and ERBB2-negative unifocal breast cancer without positive surgical margins, high nuclear grade, or lymphovascular invasion.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!